Phosphatidylserine has attracted attention over the last three decades as a nootropic and athletic performance aid. As a cortisol blocker, it acts as an adaptogen by mitigating the effects of the body’s primary stress hormone. Along with assisting with focus and improving resilience, PS is also being investigated as an adjunctive therapy for depression, ADHD, and age-related memory loss. PS is a critical component of cell membranes and is especially concentrated in the brain. Recently it was found that it assists in efficient apoptosis (Matsura, 2014). In other words, it helps facilitates the removal of senescent and precancerous cells before they cause trouble. Expanding on all the reasons this is a good thing would require its own article.

While it serves a purpose, much of cortisol’s bad press is well-deserved. As a stress hormone it is a byproduct of the “fight or flight response.” This is fine when it’s activated when you need it, but when it’s chronic it can contribute to sleep disturbances, mood disorders, muscle loss, weight gain, fatigue, heart disease, immunosuppression, and blood sugar dysregulation. In a time in which stressors are ubiquitous and anxiety is an epidemic blocking cortisol might not be a bad idea. PS is the premiere cortisol blocker with a commendable safety profile.

PS is most commonly taken by people who need long (or brief) periods of sustained focus to remain competitive with their peers. Men between 18 and 30 were tested both before and after sessions of resistance training. On average those given 400mg worked out a math problems 20% faster and with 33% fewer errors. Aside from chess-boxing (yes, that really is a sport) it is not immediately obvious how this would be helpful to anyone. As or more interesting is a study conducted on active individuals. Over a ten day period cyclists given PS increased exercise time to exhaustion by 85% of VO2 max, the maximum amount of oxygen your body can utilize during intense exercise. It correlates with overall athletic performance and, obviously, with aerobic endurance.

A 3 month study on elderly adults experiencing memory problems found a significant difference between the verum and placebo groups. Zanotta et. al, who gave elderly patients with mild cognitive impairment PS for 60 days. They saw improvements in a battery of cognitive tests, including memory. PS, an abundant molecule found throughout the body, has a commendable safety profile. Similar findings were made by an article published in Aging, in which nearly 500 participants showed improvements across a variety of cognitive and behavioral criteria.

A trial with elderly women with depression revealed that it not only improved their scores on memory tests but also alleviated their symptoms. Although it likely contributes directly to depression symptoms by reducing blood flow to the brain, an Omega-3 deficiency can reduce PS levels in the brain up to 35%. It improves depression disorders as measured by an array of tests (Maggioni, 1990). 21 children with ADHD between the ages of 4 and 19 were given 200-300mg of PS for up to four months. This alleviated symptoms of inattention, hyperactivity, and impulsivity. A 16 week study found especially marked improvements in children who took a PS/Omega-3 when compared to he placebo.

Foods with the most PS are not exactly normal fare for most people in North America: soy lecithin, cow brains, mackerel and chicken heart top the list. They are followed by an assortment of organ meats. Slightly below them are tuna, herring, mullet, and chicken. Vegetarian sources include soy, whole barley, and white beans. However, unless you have a ghoulish fondness for devouring animal organs you are probably not getting as much PS as you could from a quality supplement.

MasterMind, among other natural nootropics and adaptogens, contains phosphatidylserine. USDA organic, cGMP, Kosher, and most every other pleasant sounding certification imaginable, Allysian’s products are unlike any on the market today. Allysian Omega is made with pure premium Neptune Krill Oil®, a sustainable and industry leading omega-3 derived from Antarctic krill.


1. Komori T. The Effects of Phosphatidylserine and Omega-3 Fatty Acid-Containing Supplement on Late Life Depression. Mental Illness. Feb 24 2015;7(1).

2. Matsura T. Oxidized phosphatidylserine: production and bioactivities. Yonago acta medica. Dec 2014;57(4):119-127.

3. Naftelberg S, Abramovitch Z, Gluska S, et al. Phosphatidylserine Ameliorates Neurodegenerative Symptoms and Enhances Axonal Transport in a Mouse Model of Familial Dysautonomia. PLoS Genetics. Dec 2016;12(12).

4. Moré MI, Freitas U, Rutenberg D. Positive Effects of Soy Lecithin-Derived Phosphatidylserine plus Phosphatidic Acid on Memory, Cognition, Daily Functioning, and Mood in Elderly Patients with Alzheimer’s Disease and Dementia. Advances in Therapy. 2014;31:1247-1262.

5. Zanotta D, Puricelli S, Bonoldi G. Cognitive effects of a dietary supplement made from extract of Bacopa monnieri, astaxanthin, phosphatidylserine, and vitamin E in subjects with mild cognitive impairment: a noncomparative, exploratory clinical study. Neuropsychiatric Disease and Treatment. 2014;10:225-230.

6. Maggioni M, Picotti GB, Bondiolotti GP, et al. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta psychiatrica Scandinavica. Mar 1990;81(3):265-270.

7. Kato-Kataoka A, Sakai M, Ebina R, Nonaka C, Asano T, Miyamori T. Soybean-Derived Phosphatidylserine Improves Memory Function of the Elderly Japanese Subjects with Memory Complaints. Journal of Clinical Biochemistry and Nutrition. Nov 2010;47(3):246-255.

8. Richter Y, Herzog Y, Lifshitz Y, Hayun R, Zchut S. The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study. Clinical Interventions in Aging. 2013;8:557-563.

9. Solomon TM, Leech J, deBros GB, et al. A randomized, double-blind, placebo controlled, parallel group, efficacy study of alpha BRAIN(R) administered orally. Human psychopharmacology. Mar 2016;31(2):135-143.

10. Parker A, Gordon J, Thornton A, et al. The effects of phosphatidylserine supplementation on cognitive functioning prior and following an acute bout of resistance training in young males. Journal of the International Society of Sports Nutrition. 2010;7(Suppl 1):P2.

11. Brambilla F, Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta psychiatrica Scandinavica. Apr 1998;97(4):309-313.

12. Funfgeld EW, Baggen M, Nedwidek P, Richstein B, Mistlberger G. Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer’s type (SDAT). Progress in clinical and biological research. 1989;317:1235-1246.

13. Hirayama S, Masuda Y, Rabeler R. Effect of phosphatidylserine administration on symptoms of attention-deficit/hyperactivity disorder in children. AgroFOOD. 2006;17(5):16-20.

14. Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Alternative medicine review: a journal of clinical therapeutic.Oct 2000;5(5):402-428.

15. Hirayama S, Terasawa K, Rabeler R, et al. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. Journal of human nutrition and dietetics: the official journal of the British Dietetic Association. Apr 2014;27 Suppl 2:284-291.

16. Manor I, Magen A, Keidar D, et al. The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. European psychiatry : the journal of the Association of European Psychiatrists. Jul 2012;27(5):335-342.

17. Manor I, Magen A, Keidar D, et al. Safety of phosphatidylserine containing omega3 fatty acids in ADHD children: a double-blind placebo-controlled trial followed by an open-label extension. European psychiatry: the journal of the Association of European Psychiatrists. Aug 2013;28(6):386-391.

18. Jager R, Purpura M, Kingsley M. Phospholipids and sports performance. Journal of the International Society of Sports Nutrition. Jul 25 2007;4:5.

19. Starks MA, Starks SL, Kingsley M, Purpura M, Jäger R. The effects of phosphatidylserine on endocrine response to moderate intensity exercise. Journal of the International Society of Sports Nutrition. 2008;5:11.

20. Parker AG, Gordon J, Thornton A, et al. The effects of IQPLUS Focus on cognitive function, mood and endocrine response before and following acute exercise. Journal of the International Society of Sports Nutrition. 2011;8:16.

21. Jäger R, Purpura M, Geiss KR, et al. The effect of phosphatidylserine on golf performance. Journal of the International Society of Sports Nutrition. 2007;4:23.

22. Kim HY, Huang BX, Spector AA. Phosphatidylserine in the Brain: Metabolism and Function. Progress in lipid research. Oct 2014;0:1-18.

By |2020-03-26T23:17:06+00:00January 23rd, 2019|

About the Author:

Adam Alonzi is a writer, biotechnologist, documentary maker, futurist, inventor, programmer, and author of two obscure novels.